Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population

Journal of Korean Medical Science

Volumn 25, Issue 3, 2010, Pages 393-398

  Byun, Min Kwang ^a   Kim, Dong Soon ^b   Kim, Young Whan ^c   Chung, Man Pyo ^d   Shim, Jae Jeong ^e   Cha, Seung Ick ^f   Uh, Soo Taek ^g   Park, Choon Sik ^h   Jeong, Sung Hwan ⁱ   Park, Yong Bum ^j   Lee, Hong Lyeol ^k   Park, Moo Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e College of Medicine   (South Korea)

^f Kyungpook National University Hospital   (South Korea)

^g Soonchunhyang University College of Medicine   (South Korea)

^h Soonchunhyang University   (South Korea)

ⁱ Gachon University   (South Korea)

^j Hallym University   (South Korea)

^k Inha University Hospital   (South Korea)

more..

Author keywords

Irrigation; Koreans; Pulmonary alveolar proteinosis; Treatment outcome

Indexed keywords

ADULT; ARTICLE; BIOPSY; FEMALE; HUMAN; KOREA; LUNG ALVEOLUS PROTEINOSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BIOPSY; BRONCHOALVEOLAR LAVAGE; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; PULMONARY ALVEOLAR PROTEINOSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952298801     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.3.393     Document Type: Article

References (28)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-42.
2. Teja K, Cooper PH, Squires JE, Schnatterly PT. Pulmonary alveolar proteinosis in four siblings. N Engl J Med 1981; 305: 1390-2.
3. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993; 328: 406-10.
4. Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344: 573-9.
5. Kavuru MS, Bonfield TL, Thompson MJ. Pulmonary alveolar proteinosis. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA, editors. Textbook of pulmonary medicine, 4th ed. Philadelphia, PA: Elsevier 2006; 1716-34.
6. Ben-Dov I, Kishinevski Y, Roznman J, Soliman A, Bishara H, Zelligson E, Grief J, Mazar A, Perelman M, Vishnizer R, Weiler-Ravel D. Pulmonary alveolar proteinosis in Israel: ethnic clustering. Isr Med Assoc J 1999; 1: 75-8.
7. deMello DE, Lin Z. Pulmonary alveolar proteinosis: a review. Pediatr Pathol Mol Med 2001; 20: 413-32.
8. Goldstein LS, Kavuru MS, Curtis-McCarthy P, Christie HA, Farver C, Stoller JK. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest 1998; 114: 1357-62.
9. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 1987; 62: 499-518.
10. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215-35.
11. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, Mulligan RC. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264: 713-6.
12. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994; 91: 5592-6.
13. Seymour JF, Dunn AR, Vincent JM, Presneill JJ, Pain MC. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med 1996; 335: 1924-5.
14. Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol 2002; 105: 342-50.
15. Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR, Vincent JM, Nakata K, Kitamura T, Langton D, Pain MC, Dunn AR. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic idiopathic alveolar proteinosis. Am J Respir Crit Care Med 2001; 163: 524-31.
16. Tazawa R, Hamano E, Arai T, Ohta H, Ishimoto O, Uchida K, Watanabe M, Saito J, Takeshita M, Hirabayashi Y, Ishige I, Eishi Y, Hagiwara K, Ebina M, Inoue Y, Nakata K, Nukiwa T. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005; 171: 1142-9.
17. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349: 2527-39.
18. Carraway MS, Ghio AJ, Carter JD, Piantadosi CA. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 161: 1294-9.
19. Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, Nakata K. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875-80.
20. Asamoto H, Kitaichi M, Nishimura K, Itoh H, Izumi T. Primary pulmonary alveolar proteinosis: clinical observations of 68 patients in Japan. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33: 835-45.
21. Kim HT, Chung HS, Han SK, Shim Y, Kim KY, Han YC. A case of pulmonary alveolar proteinosis. Korean J Intern Med 1987; 33: 668-74.
22. Kim G, Lee SJ, Lee HP, Yoo CG, Han SK, Shim YS, Kim YW. The clinical characteristics of pulmonary alveolar proteinosis: experience at Seoul National University Hospital, and review of the literature. J Korean Med Sci 1999; 14: 159-64.
23. Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, Tanaka N, Yamaguchi E, Eda R, Oishi K, Tsuchihashi Y, Kaneko C, Nukiwa T, Sakatani M, Krischer JP, Nakata K. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177: 752-62.
24. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000; 55: 67-77.
25. Wang BM, Stern EJ, Schmidt RA, Pierson DJ. Diagnosing pulmonary alveolar proteinosis. A review and an update. Chest 1997; 111: 460-6.
26. Iyonaga K, Suga M, Yamamoto T, Ichiyasu H, Miyakawa H, Ando M. Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis. Eur Respir J 1999; 14: 383-9.
27. Schoch OD, Schanz U, Koller M, Nakata K, Seymour JF, Russi EW, Boehler A. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. Thorax 2002; 57: 277-80.
28. Kariman K, Kylstra JA, Spock A. Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years. Lung 1984; 162: 223-31.